Первинний гіперальдостеронізм (Ukrainian Wikipedia)

O'Shea PM, O'Donoghue D, Bashari W, Senanayake R, Joyce MB, Powlson AS, Browne D, O'Sullivan GJ, Cheow H, Mendichovszky I, Quill D, Lowery A, Lappin D, Gurnell M, Dennedy MC (May 2019). ¹¹ C-Metomidate PET/CT is a useful adjunct for lateralization of primary aldosteronism in routine clinical practice. Clinical Endocrinology. 90 (5): 670—679. doi:10.1111/cen.13942. PMID 30721535. {{cite journal}}: Недійсний |displayauthors=6 (довідка)

columbia.edu (Global: 488^th place; Ukrainian: 1,228^th place)

cumc.columbia.edu

Hyperaldosteronism (Conn's Syndrome). Columbia Adrenal Center. Архів оригіналу за 26 травня 2011.

doi.org (Global: 2^nd place; Ukrainian: 4^th place)

Schirpenbach C, Reincke M (March 2007). Primary aldosteronism: current knowledge and controversies in Conn's syndrome. Nature Clinical Practice. Endocrinology & Metabolism. 3 (3): 220—227. doi:10.1038/ncpendmet0430. PMID 17315030.
Cusumano LR, Mathevosian S, Sweigert JK, Srinivasa RN, Luhar AP, Moriarty JM (January 2021). Use of Bony Landmarks during Adrenal Venous Sampling to Guide Catheterization of the Left Adrenal Vein. The Arab Journal of Interventional Radiology (англ.). 5 (1): 25—29. doi:10.1055/s-0041-1730113. ISSN 2542-7075.
Brown MJ (September 2012). Platt versus Pickering: what molecular insight to primary hyperaldosteronism tells us about hypertension. JRSM Cardiovascular Disease. 1 (6): 1—8. doi:10.1258/cvd.2012.012020. PMC 3738367. PMID 24175075.
Choi M, Scholl UI, Yue P, Björklund P, Zhao B, Nelson-Williams C, Ji W, Cho Y, Patel A, Men CJ, Lolis E, Wisgerhof MV, Geller DS, Mane S, Hellman P, Westin G, Åkerström G, Wang W, Carling T, Lifton RP (February 2011). K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science. 331 (6018): 768—772. Bibcode:2011Sci...331..768C. doi:10.1126/science.1198785. PMC 3371087. PMID 21311022. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Beuschlein F, Boulkroun S, Osswald A, Wieland T, Nielsen HN, Lichtenauer UD, Penton D, Schack VR, Amar L, Fischer E, Walther A, Tauber P, Schwarzmayr T, Diener S, Graf E, Allolio B, Samson-Couterie B, Benecke A, Quinkler M, Fallo F, Plouin PF, Mantero F, Meitinger T, Mulatero P, Jeunemaitre X, Warth R, Vilsen B, Zennaro MC, Strom TM, Reincke M (April 2013). Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension. Nature Genetics. 45 (4): 440—4, 444e1—2. doi:10.1038/ng.2550. PMID 23416519. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Azizan EA, Poulsen H, Tuluc P, Zhou J, Clausen MV, Lieb A, Maniero C, Garg S, Bochukova EG, Zhao W, Shaikh LH, Brighton CA, Teo AE, Davenport AP, Dekkers T, Tops B, Küsters B, Ceral J, Yeo GS, Neogi SG, McFarlane I, Rosenfeld N, Marass F, Hadfield J, Margas W, Chaggar K, Solar M, Deinum J, Dolphin AC, Farooqi IS, Striessnig J, Nissen P, Brown MJ (September 2013). Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension. Nature Genetics. 45 (9): 1055—1060. doi:10.1038/ng.2716. PMID 23913004. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Åkerström T, Maharjan R, Sven Willenberg H, Cupisti K, Ip J, Moser A, Stålberg P, Robinson B, Alexander Iwen K, Dralle H, Walz MK, Lehnert H, Sidhu S, Gomez-Sanchez C, Hellman P, Björklund P (January 2016). Activating mutations in CTNNB1 in aldosterone producing adenomas. Scientific Reports. 6: 19546. Bibcode:2016NatSR...619546A. doi:10.1038/srep19546. PMC 4728393. PMID 26815163. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Tiu SC, Choi CH, Shek CC, Ng YW, Chan FK, Ng CM, Kong AP (January 2005). The use of aldosterone-renin ratio as a diagnostic test for primary hyperaldosteronism and its test characteristics under different conditions of blood sampling. The Journal of Clinical Endocrinology and Metabolism. 90 (1): 72—78. doi:10.1210/jc.2004-1149. PMID 15483077.
Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, Young WF, Montori VM (September 2008). Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. The Journal of Clinical Endocrinology and Metabolism. 93 (9): 3266—3281. doi:10.1210/jc.2008-0104. PMID 18552288. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Willenberg HS, Kolentini C, Quinkler M, Cupisti K, Krausch M, Schott M, Scherbaum WA (January 2009). The serum sodium to urinary sodium to (serum potassium)2 to urinary potassium (SUSPPUP) ratio in patients with primary aldosteronism. European Journal of Clinical Investigation. 39 (1): 43—50. doi:10.1111/j.1365-2362.2008.02060.x. PMID 19067735.
Fischer, Matan; Rosenbach, Eyal Alan; Glaser, Benjamin; Stokar, Joshua (24 лютого 2023). 131I-Iodo-cholesterol scintigraphy for primary aldosteronism lateralization in a patient with polycystic kidney disease. AACE Clinical Case Reports (English) . doi:10.1016/j.aace.2023.02.006. ISSN 2376-0605.
Chen Cardenas SM, Santhanam P (December 2020). ¹¹C-metomidate PET in the diagnosis of adrenal masses and primary aldosteronism: a review of the literature. Endocrine. 70 (3): 479—487. doi:10.1007/s12020-020-02474-3. PMID 32886316.
O'Shea PM, O'Donoghue D, Bashari W, Senanayake R, Joyce MB, Powlson AS, Browne D, O'Sullivan GJ, Cheow H, Mendichovszky I, Quill D, Lowery A, Lappin D, Gurnell M, Dennedy MC (May 2019). ¹¹ C-Metomidate PET/CT is a useful adjunct for lateralization of primary aldosteronism in routine clinical practice. Clinical Endocrinology. 90 (5): 670—679. doi:10.1111/cen.13942. PMID 30721535. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Zhou Y, Wang D, Jiang L, Ran F, Chen S, Zhou P, Wang P (December 2020). Diagnostic accuracy of adrenal imaging for subtype diagnosis in primary aldosteronism: systematic review and meta-analysis. BMJ Open. 10 (12): e038489. doi:10.1136/bmjopen-2020-038489. PMC 7780716. PMID 33384386.
Käyser SC, Dekkers T, Groenewoud HJ, van der Wilt GJ, Carel Bakx J, van der Wel MC, Hermus AR, Lenders JW, Deinum J (July 2016). Study Heterogeneity and Estimation of Prevalence of Primary Aldosteronism: A Systematic Review and Meta-Regression Analysis. The Journal of Clinical Endocrinology and Metabolism. 101 (7): 2826—2835. doi:10.1210/jc.2016-1472. PMID 27172433. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Hundemer GL, Imsirovic H, Vaidya A, Yozamp N, Goupil R, Madore F, Agharazii M, Knoll G, Sood MM (January 2022). Screening Rates for Primary Aldosteronism Among Individuals With Hypertension Plus Hypokalemia: A Population-Based Retrospective Cohort Study. Hypertension. 79 (1): 178—186. doi:10.1161/HYPERTENSIONAHA.121.18118. PMC 8664996. PMID 34657442. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Brown JM, Siddiqui M, Calhoun DA, Carey RM, Hopkins PN, Williams GH, Vaidya A (July 2020). The Unrecognized Prevalence of Primary Aldosteronism: A Cross-sectional Study. Annals of Internal Medicine. 173 (1): 10—20. doi:10.7326/M20-0065. PMC 7459427. PMID 32449886.

endocrinediseases.org (Global: low place; Ukrainian: low place)

Primary hyperaldosteronism (Conn's syndrome or aldosterone-producing adrenal tumor). Архів оригіналу за 19 квітня 2015. Процитовано 8 квітня 2015.
Primary hyperaldosteronism (Conn's syndrome or aldosterone-producing adrenal tumor). Архів оригіналу за 28 березня 2015. Процитовано 8 квітня 2015.
Primary hyperaldosteronism (Conn's syndrome or aldosterone-producing adrenal tumor). Архів оригіналу за 9 квітня 2015. Процитовано 8 квітня 2015.

harvard.edu (Global: 18^th place; Ukrainian: 74^th place)

ui.adsabs.harvard.edu

Choi M, Scholl UI, Yue P, Björklund P, Zhao B, Nelson-Williams C, Ji W, Cho Y, Patel A, Men CJ, Lolis E, Wisgerhof MV, Geller DS, Mane S, Hellman P, Westin G, Åkerström G, Wang W, Carling T, Lifton RP (February 2011). K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science. 331 (6018): 768—772. Bibcode:2011Sci...331..768C. doi:10.1126/science.1198785. PMC 3371087. PMID 21311022. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Åkerström T, Maharjan R, Sven Willenberg H, Cupisti K, Ip J, Moser A, Stålberg P, Robinson B, Alexander Iwen K, Dralle H, Walz MK, Lehnert H, Sidhu S, Gomez-Sanchez C, Hellman P, Björklund P (January 2016). Activating mutations in CTNNB1 in aldosterone producing adenomas. Scientific Reports. 6: 19546. Bibcode:2016NatSR...619546A. doi:10.1038/srep19546. PMC 4728393. PMID 26815163. {{cite journal}}: Недійсний |displayauthors=6 (довідка)

lecturio.com (Global: 5,619^th place; Ukrainian: low place)

Hyperaldosteronism. The Lecturio Medical Concept Library. Процитовано 25 липня 2021.

nih.gov (Global: 4^th place; Ukrainian: 5^th place)

pubmed.ncbi.nlm.nih.gov

Schirpenbach C, Reincke M (March 2007). Primary aldosteronism: current knowledge and controversies in Conn's syndrome. Nature Clinical Practice. Endocrinology & Metabolism. 3 (3): 220—227. doi:10.1038/ncpendmet0430. PMID 17315030.
Stowasser M, Taylor PJ, Pimenta E, Ahmed AH, Gordon RD (May 2010). Laboratory investigation of primary aldosteronism. The Clinical Biochemist. Reviews. 31 (2): 39—56. PMC 2874431. PMID 20498828.
Conn JW, Louis LH (1955). Primary aldosteronism: a new clinical entity. Transactions of the Association of American Physicians. 68: 215—31, discussion, 231—3. PMID 13299331.
Brown MJ (September 2012). Platt versus Pickering: what molecular insight to primary hyperaldosteronism tells us about hypertension. JRSM Cardiovascular Disease. 1 (6): 1—8. doi:10.1258/cvd.2012.012020. PMC 3738367. PMID 24175075.
Choi M, Scholl UI, Yue P, Björklund P, Zhao B, Nelson-Williams C, Ji W, Cho Y, Patel A, Men CJ, Lolis E, Wisgerhof MV, Geller DS, Mane S, Hellman P, Westin G, Åkerström G, Wang W, Carling T, Lifton RP (February 2011). K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science. 331 (6018): 768—772. Bibcode:2011Sci...331..768C. doi:10.1126/science.1198785. PMC 3371087. PMID 21311022. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Beuschlein F, Boulkroun S, Osswald A, Wieland T, Nielsen HN, Lichtenauer UD, Penton D, Schack VR, Amar L, Fischer E, Walther A, Tauber P, Schwarzmayr T, Diener S, Graf E, Allolio B, Samson-Couterie B, Benecke A, Quinkler M, Fallo F, Plouin PF, Mantero F, Meitinger T, Mulatero P, Jeunemaitre X, Warth R, Vilsen B, Zennaro MC, Strom TM, Reincke M (April 2013). Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension. Nature Genetics. 45 (4): 440—4, 444e1—2. doi:10.1038/ng.2550. PMID 23416519. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Azizan EA, Poulsen H, Tuluc P, Zhou J, Clausen MV, Lieb A, Maniero C, Garg S, Bochukova EG, Zhao W, Shaikh LH, Brighton CA, Teo AE, Davenport AP, Dekkers T, Tops B, Küsters B, Ceral J, Yeo GS, Neogi SG, McFarlane I, Rosenfeld N, Marass F, Hadfield J, Margas W, Chaggar K, Solar M, Deinum J, Dolphin AC, Farooqi IS, Striessnig J, Nissen P, Brown MJ (September 2013). Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension. Nature Genetics. 45 (9): 1055—1060. doi:10.1038/ng.2716. PMID 23913004. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Åkerström T, Maharjan R, Sven Willenberg H, Cupisti K, Ip J, Moser A, Stålberg P, Robinson B, Alexander Iwen K, Dralle H, Walz MK, Lehnert H, Sidhu S, Gomez-Sanchez C, Hellman P, Björklund P (January 2016). Activating mutations in CTNNB1 in aldosterone producing adenomas. Scientific Reports. 6: 19546. Bibcode:2016NatSR...619546A. doi:10.1038/srep19546. PMC 4728393. PMID 26815163. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Tiu SC, Choi CH, Shek CC, Ng YW, Chan FK, Ng CM, Kong AP (January 2005). The use of aldosterone-renin ratio as a diagnostic test for primary hyperaldosteronism and its test characteristics under different conditions of blood sampling. The Journal of Clinical Endocrinology and Metabolism. 90 (1): 72—78. doi:10.1210/jc.2004-1149. PMID 15483077.
Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, Young WF, Montori VM (September 2008). Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. The Journal of Clinical Endocrinology and Metabolism. 93 (9): 3266—3281. doi:10.1210/jc.2008-0104. PMID 18552288. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Willenberg HS, Kolentini C, Quinkler M, Cupisti K, Krausch M, Schott M, Scherbaum WA (January 2009). The serum sodium to urinary sodium to (serum potassium)2 to urinary potassium (SUSPPUP) ratio in patients with primary aldosteronism. European Journal of Clinical Investigation. 39 (1): 43—50. doi:10.1111/j.1365-2362.2008.02060.x. PMID 19067735.
Yin GS, Zhang SL, Yan L, Li F, Qi YQ, Chen ZC, Cheng H (April 2010). [New index of using serum sodium and potassium and urine sodium and potassium jointly in screening primary aldosteronism in hypertensive patients]. Zhonghua Yi Xue Za Zhi. 90 (14): 962—966. PMID 20646645.
Chen Cardenas SM, Santhanam P (December 2020). ¹¹C-metomidate PET in the diagnosis of adrenal masses and primary aldosteronism: a review of the literature. Endocrine. 70 (3): 479—487. doi:10.1007/s12020-020-02474-3. PMID 32886316.
O'Shea PM, O'Donoghue D, Bashari W, Senanayake R, Joyce MB, Powlson AS, Browne D, O'Sullivan GJ, Cheow H, Mendichovszky I, Quill D, Lowery A, Lappin D, Gurnell M, Dennedy MC (May 2019). ¹¹ C-Metomidate PET/CT is a useful adjunct for lateralization of primary aldosteronism in routine clinical practice. Clinical Endocrinology. 90 (5): 670—679. doi:10.1111/cen.13942. PMID 30721535. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Zhou Y, Wang D, Jiang L, Ran F, Chen S, Zhou P, Wang P (December 2020). Diagnostic accuracy of adrenal imaging for subtype diagnosis in primary aldosteronism: systematic review and meta-analysis. BMJ Open. 10 (12): e038489. doi:10.1136/bmjopen-2020-038489. PMC 7780716. PMID 33384386.
Trono D, Cereda JM, Favre L (August 1983). [Pseudo-Conn's syndrome due to intoxication with nonalcoholic pastis]. Schweizerische Medizinische Wochenschrift (фр.). 113 (31–32): 1092—1095. PMID 6623028.
Käyser SC, Dekkers T, Groenewoud HJ, van der Wilt GJ, Carel Bakx J, van der Wel MC, Hermus AR, Lenders JW, Deinum J (July 2016). Study Heterogeneity and Estimation of Prevalence of Primary Aldosteronism: A Systematic Review and Meta-Regression Analysis. The Journal of Clinical Endocrinology and Metabolism. 101 (7): 2826—2835. doi:10.1210/jc.2016-1472. PMID 27172433. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Hundemer GL, Imsirovic H, Vaidya A, Yozamp N, Goupil R, Madore F, Agharazii M, Knoll G, Sood MM (January 2022). Screening Rates for Primary Aldosteronism Among Individuals With Hypertension Plus Hypokalemia: A Population-Based Retrospective Cohort Study. Hypertension. 79 (1): 178—186. doi:10.1161/HYPERTENSIONAHA.121.18118. PMC 8664996. PMID 34657442. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Brown JM, Siddiqui M, Calhoun DA, Carey RM, Hopkins PN, Williams GH, Vaidya A (July 2020). The Unrecognized Prevalence of Primary Aldosteronism: A Cross-sectional Study. Annals of Internal Medicine. 173 (1): 10—20. doi:10.7326/M20-0065. PMC 7459427. PMID 32449886.

ncbi.nlm.nih.gov

Stowasser M, Taylor PJ, Pimenta E, Ahmed AH, Gordon RD (May 2010). Laboratory investigation of primary aldosteronism. The Clinical Biochemist. Reviews. 31 (2): 39—56. PMC 2874431. PMID 20498828.
Brown MJ (September 2012). Platt versus Pickering: what molecular insight to primary hyperaldosteronism tells us about hypertension. JRSM Cardiovascular Disease. 1 (6): 1—8. doi:10.1258/cvd.2012.012020. PMC 3738367. PMID 24175075.
Choi M, Scholl UI, Yue P, Björklund P, Zhao B, Nelson-Williams C, Ji W, Cho Y, Patel A, Men CJ, Lolis E, Wisgerhof MV, Geller DS, Mane S, Hellman P, Westin G, Åkerström G, Wang W, Carling T, Lifton RP (February 2011). K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science. 331 (6018): 768—772. Bibcode:2011Sci...331..768C. doi:10.1126/science.1198785. PMC 3371087. PMID 21311022. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Åkerström T, Maharjan R, Sven Willenberg H, Cupisti K, Ip J, Moser A, Stålberg P, Robinson B, Alexander Iwen K, Dralle H, Walz MK, Lehnert H, Sidhu S, Gomez-Sanchez C, Hellman P, Björklund P (January 2016). Activating mutations in CTNNB1 in aldosterone producing adenomas. Scientific Reports. 6: 19546. Bibcode:2016NatSR...619546A. doi:10.1038/srep19546. PMC 4728393. PMID 26815163. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Zhou Y, Wang D, Jiang L, Ran F, Chen S, Zhou P, Wang P (December 2020). Diagnostic accuracy of adrenal imaging for subtype diagnosis in primary aldosteronism: systematic review and meta-analysis. BMJ Open. 10 (12): e038489. doi:10.1136/bmjopen-2020-038489. PMC 7780716. PMID 33384386.
Hundemer GL, Imsirovic H, Vaidya A, Yozamp N, Goupil R, Madore F, Agharazii M, Knoll G, Sood MM (January 2022). Screening Rates for Primary Aldosteronism Among Individuals With Hypertension Plus Hypokalemia: A Population-Based Retrospective Cohort Study. Hypertension. 79 (1): 178—186. doi:10.1161/HYPERTENSIONAHA.121.18118. PMC 8664996. PMID 34657442. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Brown JM, Siddiqui M, Calhoun DA, Carey RM, Hopkins PN, Williams GH, Vaidya A (July 2020). The Unrecognized Prevalence of Primary Aldosteronism: A Cross-sectional Study. Annals of Internal Medicine. 173 (1): 10—20. doi:10.7326/M20-0065. PMC 7459427. PMID 32449886.

pfizer.com (Global: low place; Ukrainian: low place)

labeling.pfizer.com

Inspra (eplerenone) [prescribing information]. Архів оригіналу за 8 серпня 2011. Процитовано 17 липня 2011.

primaryaldosteronism.org (Global: low place; Ukrainian: low place)

Welcome to the Primary Aldosteronism Foundation (амер.). Процитовано 5 березня 2021.

spark-pa.com (Global: low place; Ukrainian: low place)

Spark-PA – Spark-PA is a clinical research study exploring an investigational study drug that may help people with primary aldosteronism (PA) lower their blood pressure (амер.). Архів оригіналу за 2 серпня 2021. Процитовано 5 березня 2021.

ubht.nhs.uk (Global: low place; Ukrainian: low place)

Renin/Aldosterone Protocol. United Bristol Healthcare NHS Trust. Архів оригіналу за 13 серпня 2007.

web.archive.org (Global: 1^st place; Ukrainian: 1^st place)

Primary hyperaldosteronism (Conn's syndrome or aldosterone-producing adrenal tumor). Архів оригіналу за 19 квітня 2015. Процитовано 8 квітня 2015.
Primary hyperaldosteronism (Conn's syndrome or aldosterone-producing adrenal tumor). Архів оригіналу за 28 березня 2015. Процитовано 8 квітня 2015.
Primary hyperaldosteronism (Conn's syndrome or aldosterone-producing adrenal tumor). Архів оригіналу за 9 квітня 2015. Процитовано 8 квітня 2015.
Endocrine surgery principles and practice. London: Springer. 2009. с. 367. ISBN 9781846288814. Архів оригіналу за 30 червня 2016.
Textbook of nephro-endocrinology. Amsterdam: Academic. 2009. с. 372. ISBN 9780080920467. Архів оригіналу за 30 червня 2016.
Inspra (eplerenone) [prescribing information]. Архів оригіналу за 8 серпня 2011. Процитовано 17 липня 2011.
Hyperaldosteronism (Conn's Syndrome). Columbia Adrenal Center. Архів оригіналу за 26 травня 2011.
Spark-PA – Spark-PA is a clinical research study exploring an investigational study drug that may help people with primary aldosteronism (PA) lower their blood pressure (амер.). Архів оригіналу за 2 серпня 2021. Процитовано 5 березня 2021.

worldcat.org (Global: 5^th place; Ukrainian: 9^th place)

search.worldcat.org

Cusumano LR, Mathevosian S, Sweigert JK, Srinivasa RN, Luhar AP, Moriarty JM (January 2021). Use of Bony Landmarks during Adrenal Venous Sampling to Guide Catheterization of the Left Adrenal Vein. The Arab Journal of Interventional Radiology (англ.). 5 (1): 25—29. doi:10.1055/s-0041-1730113. ISSN 2542-7075.
Fischer, Matan; Rosenbach, Eyal Alan; Glaser, Benjamin; Stokar, Joshua (24 лютого 2023). 131I-Iodo-cholesterol scintigraphy for primary aldosteronism lateralization in a patient with polycystic kidney disease. AACE Clinical Case Reports (English) . doi:10.1016/j.aace.2023.02.006. ISSN 2376-0605.

Первинний гіперальдостеронізм (Ukrainian Wikipedia)

aaceclinicalcasereports.com (Global: low place; Ukrainian: low place)

archive.org (Global: 6th place; Ukrainian: 6th place)

archive.today (Global: 14th place; Ukrainian: 18th place)

books.google.com (Global: 3rd place; Ukrainian: 11th place)

cam.ac.uk (Global: 670th place; Ukrainian: 721st place)

repository.cam.ac.uk

columbia.edu (Global: 488th place; Ukrainian: 1,228th place)

cumc.columbia.edu

doi.org (Global: 2nd place; Ukrainian: 4th place)

endocrinediseases.org (Global: low place; Ukrainian: low place)

harvard.edu (Global: 18th place; Ukrainian: 74th place)

ui.adsabs.harvard.edu

lecturio.com (Global: 5,619th place; Ukrainian: low place)

nih.gov (Global: 4th place; Ukrainian: 5th place)

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

pfizer.com (Global: low place; Ukrainian: low place)

labeling.pfizer.com

primaryaldosteronism.org (Global: low place; Ukrainian: low place)

spark-pa.com (Global: low place; Ukrainian: low place)

ubht.nhs.uk (Global: low place; Ukrainian: low place)

web.archive.org (Global: 1st place; Ukrainian: 1st place)

worldcat.org (Global: 5th place; Ukrainian: 9th place)

search.worldcat.org

archive.org (Global: 6^th place; Ukrainian: 6^th place)

archive.today (Global: 14^th place; Ukrainian: 18^th place)

books.google.com (Global: 3^rd place; Ukrainian: 11^th place)

cam.ac.uk (Global: 670^th place; Ukrainian: 721^st place)

columbia.edu (Global: 488^th place; Ukrainian: 1,228^th place)

doi.org (Global: 2^nd place; Ukrainian: 4^th place)

harvard.edu (Global: 18^th place; Ukrainian: 74^th place)

lecturio.com (Global: 5,619^th place; Ukrainian: low place)

nih.gov (Global: 4^th place; Ukrainian: 5^th place)

web.archive.org (Global: 1^st place; Ukrainian: 1^st place)

worldcat.org (Global: 5^th place; Ukrainian: 9^th place)